Characterizing cancers by prevalence on the PD-L1/CD8 axis

被引：0
|
作者：
Schmidt, Guenter [1 ]
Steele, Keith [2 ]
Meier, Armin [1 ]
Herz, Thomas [1 ]
Tan, Tze Heng [1 ]
Higgs, Brandon [2 ]
Althammer, Sonja [1 ]
Huss, Ralf [1 ]
机构：
[1] Definiens AG, Munich, Germany
[2] MedImmune LLC, Gaithersburg, MD USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P83
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 and CD8 Expression in Poorly Differentiated Cervical Squamous Cell Carcinoma
    Saglam, Ozlen
    Zhou, Jun-Min
    Wang, Xuefeng
    Conejo-Garcia, Jose
    LABORATORY INVESTIGATION, 2019, 99
  • [22] Abundance of PD-1 and PD-L1 expressing CD8 tcells in the liver may be key to hepatic tolerogenicity
    Wang, Pengyun
    Jassem, Wayel
    Longhi, Maria Serena
    Heaton, Nigel
    HEPATOLOGY, 2007, 46 (04) : 496A - 497A
  • [23] IMMUNOResist: Defining the Immunophenotype of Immunotherapy Resistance with PD-L1 and CD8 Novel Tracer PET
    Hegi-Johnson, F.
    Akhurst, T.
    John, T.
    Scott, A.
    Parakh, S.
    Blyth, B.
    Wong, S.
    MacManus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S190 - S191
  • [24] Significance of Immunotyping by CD8 and PD-L1 Immune Checkpoint Inhibitor in Epithelial Ovarian Carcinoma
    Srinivasan, Radhika
    Bansal, Akriti
    Rohilla, Manish
    Rai, Bhavana
    Rajwanshi, Arvind
    Suri, Vanita
    Saha, Subhas
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1137 - 1139
  • [25] The Prognostic Impact of PD-L1 and CD8 Expression in Anal Cancer Patients Treated with Chemoradiotherapy
    Jiang, W. N.
    Chan, A. M. Y.
    Urgoiti, G. Roldan
    Kornaga, E.
    Mathen, P.
    Yeung, R.
    Konno, M.
    Lee, S.
    Box, A.
    Kobel, M.
    Joseph, K. J.
    Doll, C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S62 - S63
  • [26] Assessment of PD-L1 and CD8 Expression in Lung Cancer Using RNA in Situ Hybridisation
    Baird, A.
    Wright, M.
    Mccarra, L.
    Thirstrup, H.
    Schonau, A.
    Cuffe, S.
    Finn, S.
    Gray, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S775 - S775
  • [27] Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
    Chen, Wei-Chung
    Wu, Chun-Chieh
    Chen, Yi-Hsun
    Lee, Jui-Ying
    Wang, Yao-Kuang
    Wu, Nian-Siou
    Wu, Ming-Tsang
    Wu, I-Chen
    BIOMEDICINES, 2022, 10 (08)
  • [28] The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy
    Chan, Angela M. Y.
    Urgoiti, Gloria Roldan
    Jiang, Will
    Lee, Sandra
    Kornaga, Elizabeth
    Mathen, Peter
    Yeung, Rosanna
    Enwere, Emeka K.
    Box, Alan
    Konno, Mie
    Koebel, Martin
    Joseph, Kurian
    Doll, Corinne M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma
    Nishida, Haruto
    Kondo, Yoshihiko
    Kusaba, Takahiro
    Kawamura, Kazuhiro
    Oyama, Yuzo
    Daa, Tsutomu
    PLOS ONE, 2023, 18 (02):
  • [30] Halioseek™, a dual CD8 and PD-L1 IVD assay to improve NSCLC patients stratification
    Monville, Florence
    Prestat, Emmanuel
    Vanhille, Laurent
    Adam, Julien
    Coslet, Sergiu
    Lauge, Caroline
    Davin, Caroline
    Losch, Merle Sophie
    Batista, Luciana
    Fieschi, Jacques
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345